Effects of Myofascial Release in Nonspecific Chronic Low Back Pain: A Randomized Clinical Trial
| Autor: | Maria Dolores Arguisuelas, Julio Doménech-Fernández, Isabel Martínez-hurtado, Juan Francisco Lisón, Daniel Sánchez-Zuriaga |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Treatment outcome MEDLINE law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Surveys and Questionnaires Medicine Humans Orthopedics and Sports Medicine In patient 030212 general & internal medicine Physical Therapy Modalities Aged business.industry Middle Aged Myofascial release Chronic low back pain Treatment Outcome Physical therapy Female Neurology (clinical) Chronic Pain business Low Back Pain 030217 neurology & neurosurgery |
| Zdroj: | Spine. 42(9) |
| ISSN: | 1528-1159 |
| Popis: | Double-blind, randomized parallel sham-controlled trial with concealed allocation and intention-to treat analysis.To investigate the effects of an isolate myofascial release (MFR) protocol on pain, disability, and fear-avoidance beliefs in patients with chronic low back pain (CLBP).MFR is a form of manual medicine widely used by physiotherapists in the management of different musculoskeletal pathologies. Up to this moment, no previous studies have reported the effects of an isolated MFR treatment in patients with CLBP.Fifty-four participants, with nonspecific CLBP, were randomized to MFR group (n = 27) receiving four sessions of myofascial treatment, each lasting 40 minutes, and to control group (n = 27) receiving a sham MFR. Variables studied were pain measured by means Short Form McGill Pain Questionnaire (SF-MPQ) and visual analog scale (VAS), disability measured with Roland Morris Questionnaire, and fear-avoidance beliefs measured with Fear-Avoidance Beliefs Questionnaire.Subjects receiving MFR displayed significant improvements in pain (SF-MPQ) (mean difference -7.8; 95% confidence interval [CI]: -14.5 to -1.1, P = 0.023) and sensory SF-MPQ subscale (mean difference -6.1; 95% CI: -10.8 to -1.5, P = 0.011) compared to the sham group, but no differences were found in VAS between groups. Disability and the Fear-Avoidance Beliefs Questionnaire score also displayed a significant decrease in the MFR group (P 0.05) as compared to sham MFR.MFR therapy produced a significant improvement in both pain and disability. Because the minimal clinically important differences in pain and disability are, however, included in the 95% CI, we cannot know whether this improvement is clinically relevant.2. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|